Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$2.0MFederal grants as PI3 awards
2Patents grantedLatest Dec 23, 2025
26Papers60 citations
Federal awards and patents by year
AwardsPatents
3 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 30, 2023 | NIH | SBIR Phase II An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia | $476K | CELLECTAR BIOSCIENCES, INC. |
| Aug 31, 2022 | NIH | SBIR Phase II An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia | $756K | CELLECTAR BIOSCIENCES, INC. |
| Aug 28, 2021 | NIH | SBIR Phase II An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia | $763K | CELLECTAR BIOSCIENCES, INC. |
3 patents as inventor
- US 12496346CELLECTAR BIOSCIENCES, INC.Dec 16, 2025
- US 12503479CELLECTAR BIOSCIENCES, INC.Dec 23, 2025
- US CELLECTAR BIOSCIENCES, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,045
Awards as PI#822
Patents#102
Companies
- CELLECTAR BIOSCIENCES, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.